Citation only
via OpenAlex
β-Synuclein Inhibits Formation of α-Synuclein Protofibrils: A Possible Therapeutic Strategy against Parkinson's Disease
June-Young Park, Peter T. Lansbury
Biochemistry · 2003 · ▲ 159 citations
Abstract
Parkinson's disease (PD) is an age-associated and progressive movement disorder that is characterized by dopaminergic neuronal loss in the substantia nigra and, at autopsy, by fibrillar alpha-synuclein inclusions, or Lewy bodies. Despite the qualitative correlation between alpha-synuclein fibrils and disease, in vitro biophysical studies strongly suggest that prefibrillar alpha-synuclein oligomers, or protofibrils, are pathogenic. Consistent with this proposal, transgenic mice that express human alpha-synuclein develop a Parkinsonian movement disorder concurrent with nonfibrillar alpha-synuclein inclusions and the loss of dopaminergic terminii. Double-transgenic progeny of these mice that also express human beta-synuclein, a homologue of alpha-synuclein, show significant amelioration of all three phenotypes. We demonstrate here that beta- and gamma-synuclein (a third homologue that is expressed primarily in peripheral neurons) are natively unfolded in monomeric form, but structured in protofibrillar form. Beta-synuclein protofibrils do not bind to or permeabilize synthetic vesicles, unlike protofibrils comprising alpha-synuclein or gamma-synuclein. Significantly, beta-synuclein inhibits the generation of A53T alpha-synuclein protofibrils and fibrils. This finding provides a rationale for the phenotype of the double-transgenic mice and suggests a therapeutic strategy for PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1021/bi020604a
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Park, J., & Lansbury, P.T. (2003). β-Synuclein Inhibits Formation of α-Synuclein Protofibrils: A Possible Therapeutic Strategy against Parkinson's Disease. <em>Biochemistry</em>. https://doi.org/10.1021/bi020604a
Vancouver
Park J, Lansbury PT. β-Synuclein Inhibits Formation of α-Synuclein Protofibrils: A Possible Therapeutic Strategy against Parkinson's Disease. Biochemistry. 2003. doi:10.1021/bi020604a.
BibTeX
@article{juneyoung2003Synucl,
title = {β-Synuclein Inhibits Formation of α-Synuclein Protofibrils: A Possible Therapeutic Strategy against Parkinson's Disease},
author = {June-Young Park and Peter T. Lansbury},
journal = {Biochemistry},
year = {2003},
doi = {10.1021/bi020604a},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
European Journal of Neuroscience 2004
Open access · OA
Risk factors for dopaminergic neuron loss in human α‐synuclein transgenic mice
Molecular Brain 2010
Open access · CC-BY
Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
Translational Neurodegeneration 2023
Open access · CC-BY
Role of dopamine in the pathophysiology of Parkinson’s disease
Annual Review of Neuroscience 2021
Open access · OA
Parkinson's Disease Genetics and Pathophysiology
CHEST Journal 2011
Citation only
COPD, Bone Metabolism, and Osteoporosis
Frontiers in Aging Neuroscience 2020
Open access · CC-BY